Gene Page:NOS3
概括?
基因 | 4846 |
象征 | NOS3 |
Synonyms | ecnos | eNos |
Description | nitric oxide synthase 3 |
Reference | MIM:163729|HGNC:HGNC:7876|Ensembl:ENSG00000164867|HPRD:01224|Vega:OTTHUMG00000158343 |
Gene type | protein-coding |
Map location | 7q36 |
Pascal p-value | 0.26 |
TADA p-value | 0.023 |
eGene | Myers' cis & trans 元 |
Support | COMPOSITESET |
数据源中的基因
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DNM:Fromer_2014 | Whole Exome Sequencing analysis | This study reported a WES study of 623 schizophrenia trios, reporting DNMs using genomic DNA. | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Literature | High-throughput literature-search | 与Sc Co-occurancehizophrenia keywords: schizophrenia,schizophrenic,schizophrenias | Click to show details |
第一节遗传学和表观遗传学注释
DNM table
Gene | Chromosome | Position | Ref | Alt | Transcript | AA change | Mutation type | 筛 | CG46 | Trait | Study |
---|---|---|---|---|---|---|---|---|---|---|---|
NOS3 | chr7 | 150707820 | T | G | NM_000603 | p.941S>A | missense | 精神分裂症 | DNM:Fromer_2014 |
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs7370564 | 0 | NOS3 | 4846 | 0.15 | trans | |||
rs443832 | chr16 | 83779643 | NOS3 | 4846 | 0.18 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0003785 | actin monomer binding | 新闻学会 | 17502619 | |
GO:0005506 | 铁离子结合 | IEA | - | |
GO:0005509 | 钙离子结合 | IEA | - | |
GO:0005516 | calmodulin binding | IEA | - | |
GO:0004517 | nitric-oxide synthase activity | IEA | - | |
GO:0020037 | heme binding | IEA | - | |
GO:0008270 | zinc ion binding | IEA | - | |
GO:0010181 | FMN binding | IEA | - | |
去:0009055 | 电子载体活动 | IEA | - | |
GO:0016491 | oxidoreductase activity | IEA | - | |
GO:0034617 | tetrahydrobiopterin binding | IDA | 7488039 | |
GO:0034618 | arginine binding | IDA | 7488039 | |
GO:0046870 | cadmium ion binding | NAS | 7488039 | |
GO:0050660 | FAD binding | IEA | - | |
GO:0050661 | NADP binding | IEA | - | |
生物过程 | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0001542 | ovulation from ovarian follicle | IEA | - | |
GO:0002028 | 钠离子运输的调节 | IEA | - | |
GO:0003100 | regulation of systemic arterial blood pressure by endothelin | IMP | 8999856 | |
GO:0001974 | blood vessel remodeling | ISS | - | |
GO:0006527 | arginine catabolic process | IDA | 1378832|7488039 | |
GO:0008217 | regulation of blood pressure | NAS | 7504210 | |
GO:0010544 | negative regulation of platelet activation | NAS | 7504210 | |
GO:0008285 | negative regulation of cell proliferation | ISS | - | |
GO:0009408 | response to heat | NAS | 18048451 | |
GO:0007612 | learning | IEA | - | |
去:0006809 | nitric oxide biosynthetic process | IEA | - | |
GO:0007005 | 线粒体组织 | ISS | - | |
GO:0006916 | anti-apoptosis | ISS | - | |
GO:0014740 | negative regulation of muscle hyperplasia | ISS | - | |
GO:0014806 | smooth muscle hyperplasia | ISS | - | |
GO:0051346 | negative regulation of hydrolase activity | IEA | - | |
GO:0031284 | positive regulation of guanylate cyclase activity | IMP | 17502619 | |
GO:0031284 | positive regulation of guanylate cyclase activity | ISS | - | |
GO:0034405 | response to fluid shear stress | IEP | 10376603 | |
GO:0030324 | lung development | IEA | - | |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | IEA | - | |
GO:0043267 | negative regulation of potassium ion transport | IEA | - | |
GO:0045766 | positive regulation of angiogenesis | ISS | - | |
GO:0045909 | positive regulation of vasodilation | NAS | 18048451 | |
GO:0050880 | regulation of blood vessel size | ISS | - | |
GO:0050880 | regulation of blood vessel size | NAS | 7504210 | |
GO:0043542 | endothelial cell migration | IMP | 8999856 | |
GO:0055114 | oxidation reduction | IEA | - | |
GO:0051926 | negative regulation of calcium ion transport | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0000139 | Golgi membrane | 经验 | 9188442|9580552|10781589 |11149895|16722822 |16807357 |
|
GO:0005794 | Golgi apparatus | IEA | - | |
GO:0005829 | cytosol | 经验 | 7512951|10559837 | |
GO:0005856 | cytoskeleton | IEA | - | |
GO:0005634 | nucleus | ISS | - | |
GO:0005737 | 细胞质 | IEA | - | |
GO:0005901 | caveola | IDA | 17502619|17848177 | |
GO:0005886 | plasma membrane | IEA | - |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG ARGININE AND PROLINE METABOLISM | 54 | 39 | 该途径中的所有SZGR 2.0基因 |
KEGG CALCIUM SIGNALING PATHWAY | 178 | 134 | 该途径中的所有SZGR 2.0基因 |
KEGG VEGF SIGNALING PATHWAY | 76 | 53 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA第一途径 | 33 | 24 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA GCR PATHWAY | 22 | 17 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA HIF PATHWAY | 15 | 12 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA VEGF PATHWAY | 29 | 18 | 该途径中的所有SZGR 2.0基因 |
PID ER NONGENOMIC PATHWAY | 41 | 35 | 该途径中的所有SZGR 2.0基因 |
PID FRA PATHWAY | 37 | 28 | 该途径中的所有SZGR 2.0基因 |
PID ANGIOPOIETIN RECEPTOR PATHWAY | 50 | 41 | 该途径中的所有SZGR 2.0基因 |
PID TXA2PATHWAY | 57 | 43 | 该途径中的所有SZGR 2.0基因 |
PID SHP2 PATHWAY | 58 | 46 | 该途径中的所有SZGR 2.0基因 |
PID VEGFR1 PATHWAY | 26 | 23 | 该途径中的所有SZGR 2.0基因 |
PID VEGFR1 2 PATHWAY | 69 | 57 | 该途径中的所有SZGR 2.0基因 |
PID THROMBIN PAR1 PATHWAY | 43 | 32 | 该途径中的所有SZGR 2.0基因 |
REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 13 | 9 | 该途径中的所有SZGR 2.0基因 |
REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | 33 | 15 | 该途径中的所有SZGR 2.0基因 |
REACTOME ENOS ACTIVATION AND REGULATION | 20 | 14 | 该途径中的所有SZGR 2.0基因 |
REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 25 | 19 | 该途径中的所有SZGR 2.0基因 |
REACTOME PLATELET HOMEOSTASIS | 78 | 49 | 该途径中的所有SZGR 2.0基因 |
REACTOME HEMOSTASIS | 466 | 331 | 该途径中的所有SZGR 2.0基因 |
GARY CD5 TARGETS UP | 473 | 314 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN APOPTOSIS BY SERUM DEPRIVATION DN | 234 | 147 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN RESPONSE TO MC AND DOXORUBICIN UP | 612 | 367 | 该途径中的所有SZGR 2.0基因 |
Hatada甲基化在肺癌中 | 390 | 236 | 该途径中的所有SZGR 2.0基因 |
SANA TNF SIGNALING DN | 90 | 57 | 该途径中的所有SZGR 2.0基因 |
MARIADASON REGULATED BY HISTONE ACETYLATION UP | 83 | 49 | 该途径中的所有SZGR 2.0基因 |
李小脑老化 | 84 | 58 | 该途径中的所有SZGR 2.0基因 |
Hillion HMGA1B目标 | 92 | 68 | 该途径中的所有SZGR 2.0基因 |
MATZUK OVULATION | 14 | 10 | 该途径中的所有SZGR 2.0基因 |
Matzuk减数分裂和DNA修复 | 39 | 26 | 该途径中的所有SZGR 2.0基因 |
WINTER HYPOXIA METAGENE | 242 | 168 | 该途径中的所有SZGR 2.0基因 |
VART KSHV INFECTION ANGIOGENIC MARKERS UP | 165 | 118 | 该途径中的所有SZGR 2.0基因 |
SHEDDEN LUNG CANCER GOOD SURVIVAL A4 | 196 | 124 | 该途径中的所有SZGR 2.0基因 |
MIKKELSEN IPS LCP WITH H3K4ME3 | 174 | 100 | 该途径中的所有SZGR 2.0基因 |
MIKKELSEN ES LCP WITH H3K4ME3 | 142 | 80 | 该途径中的所有SZGR 2.0基因 |
figueroa aml甲基化簇3 dn | 42 | 24 | 该途径中的所有SZGR 2.0基因 |
FOSTER KDM1A TARGETS DN | 211 | 119 | 该途径中的所有SZGR 2.0基因 |